Industry: Biden Admin Must Restore Trust In FDA’s Scientific Decisions

By Kelly Lienhard / November 19, 2020 at 1:17 PM
Drug and device industry lawyers say the incoming Biden administration will need to focus on restoring the public’s trust in FDA, especially with potential COVID-19 vaccine emergency authorizations right around the corner. Transparency is key, one lawyer says, adding that allowing the agency to exercise more control over its communications is one way to restore open communication. A researcher with the Union of Concerned Scientists also believes the Biden administration should focus on examining FDA’s decision-making process and look at...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.